Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Processa Pharmaceuticals Inc (NQ: PCSA ) 1.380 -0.010 (-0.72%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 30, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Processa Pharmaceuticals Inc < Previous 1 2 3 Next > InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Announces Q2 2024 Financial Results, Provides Updates August 28, 2024 Via Investor Brand Network Exposures Product Safety BioMedNewsBreaks — Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Announces Positive Data from Two Preclinical Studies of NGC-Iri August 19, 2024 Via Investor Brand Network InvestorNewsBreaks – Processa Pharmaceuticals Inc.’s (NASDAQ: PCSA) IND Application for Phase 2 Clinical Trial of NGC-Cap in Patients with Breast Cancer Receives FDA Clearance July 30, 2024 Via Investor Brand Network Exposures Product Safety InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Appoints Seasoned Veteran as Chief Financial Officer July 17, 2024 Via Investor Brand Network Exposures Product Safety InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Announces Positive Efficacy Results from Phase 1b Trial June 11, 2024 Via Investor Brand Network Exposures Product Safety BioMedNewsBreaks — Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Announces Participation at Upcoming EF Hutton Global Conference May 06, 2024 Via Investor Brand Network Exposures Product Safety InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Appoints Dr. Steven Cha to Lead Clinical Development of Oncology Programs April 30, 2024 Via Investor Brand Network Exposures Product Safety InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Presents New Data from NGC-Cap Phase 1b Trial at AACR Annual Meeting April 11, 2024 Via Investor Brand Network Exposures Product Safety BioMedNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) to Present at Upcoming MedInvest Conference March 28, 2024 Via Investor Brand Network Exposures Product Safety TinyGemsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) to Present at Upcoming MedInvest Conference March 28, 2024 Via Investor Brand Network Exposures Product Safety InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Announces Participation at American Association for Cancer Research Annual Meeting March 25, 2024 Via Investor Brand Network Exposures Product Safety InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) to Present at 2024 BIO CEO & Investor Conference February 21, 2024 Via Investor Brand Network Exposures Product Safety InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Closes on $7M Public Offering February 02, 2024 Via Investor Brand Network Exposures Product Safety Nasdaq Stocks Above $2 to Watch Now! LVTX, INBS, IKT, PCSA, DYAI January 29, 2024 Via AB Newswire Topics Retirement Exposures Pension InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Releases Pricing Information for $7M Public Offering January 26, 2024 Via Investor Brand Network Exposures Product Safety Processa Pharmaceuticals Announces Pricing of $7.0 Million Public Offering January 26, 2024 From Processa Pharmaceuticals, Inc. Via GlobeNewswire InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Completes Phase 1b Safety Evaluation of NGC-Cap January 25, 2024 Via Investor Brand Network Exposures Product Safety InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Announces Plans to Expand NGC-Cap Program into Advanced or Metastatic Breast Cancer January 19, 2024 Via Investor Brand Network Exposures Product Safety InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Announces 1-for-20 Reverse Stock Split January 18, 2024 Via Investor Brand Network Exposures Product Safety InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Announces Participation in Upcoming Biotech Showcase 2024 January 03, 2024 Via Investor Brand Network Exposures Product Safety InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Provides Interim Analysis from Phase 1b NGC-Cap Trial December 19, 2023 Via Investor Brand Network Exposures Product Safety InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Gains Helpful Guidance on Overall Design of NGC-Cap Phase 2 Study December 13, 2023 Via Investor Brand Network Exposures Product Safety InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Announces Participation in December MedInvest Oncology Investor Conference November 30, 2023 Via Investor Brand Network Exposures Product Safety InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Releases Shareholder Letter November 29, 2023 Via Investor Brand Network Exposures Product Safety InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Reports Unexpected Passing of Board Member November 14, 2023 Via Investor Brand Network Exposures Product Safety InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) to Present at Upcoming Orphan Drugs and Rare Diseases Global Congress November 09, 2023 Via Investor Brand Network Exposures Product Safety InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Creates Advisory Board, Names Renowned Experts as Members November 01, 2023 Via Investor Brand Network Exposures Product Safety InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Announces Participation at Upcoming ThinkEquity Conference October 13, 2023 Via Investor Brand Network Exposures Product Safety InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) to Participate at Upcoming H.C. Wainwright Global Investment Conference September 06, 2023 Via Investor Brand Network Exposures Product Safety InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Shares Encouraging Results on Potential Cancer Treatment Approach August 17, 2023 Via Investor Brand Network Exposures Product Safety < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.